VERPA
PFE icon

Virginia Estate & Retirement Planning Advisors’s Pfizer PFE Stock Holding History

Virginia Estate & Retirement Planning Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$50.9K Buy
2,114
+865
+69% +$22.6K 0.06% 45
2026
Q1 		$35.1K Buy
+1,249
New +$33.3K 0.06% 38

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Virginia Estate & Retirement Planning Advisors's PFE Position: Q2 2026 in Review

Virginia Estate & Retirement Planning Advisors increased its Pfizer (PFE) stake by 69% in Q2 2026, buying an estimated $22.6K and bringing the position to 2,114 shares worth $50.9K. The position accounts for 0.06% of the portfolio, ranked #45.

Virginia Estate & Retirement Planning Advisors first reported a position in PFE in Q1 2026 and has held it in 2 quarters since. 2,799 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Virginia Estate & Retirement Planning Advisors held 2,114 shares of Pfizer worth $50.9K as of Q2 2026.
  • Virginia Estate & Retirement Planning Advisors bought 865 Pfizer shares in Q2 2026, an estimated $22.6K.
  • Pfizer made up 0.06% of Virginia Estate & Retirement Planning Advisors's portfolio in Q2 2026, its #45 holding.
  • Virginia Estate & Retirement Planning Advisors first reported a position in Pfizer in Q1 2026 and has held it in 2 quarters since.
  • 2,799 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Virginia Estate & Retirement Planning Advisors's 13F filing for Q2 2026, filed 28 Jul 2026.